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Introduction
Irritable bowel syndrome (IBS) is a disorder defined by the presence 
of recurring episodes of abdominal pain in association with altered 
bowel habits and no evidence of a structural or easily identifiable 
biochemical abnormality that might explain these symptoms.1
IBS affects up to 20% of the population, making it a fairly common 
gastrointestinal (GI) disorder, and affects more women than men.  As 
a chronic, functional GI disorder, it significantly decreases patients’ 
quality of life.1-3 
The Rome Criteria is the standard symptoms-based criteria for the 
diagnosis of IBS. The Rome IV criteria has recently replaced the 
Rome III version (Table 1).4 
There are significant differences between Rome IV and Rome III 
criteria. “Discomfort” has been removed from the criteria (Table 
1; Box 1); only what is volunteered as “pain” meets the major 
criterion. The threshold for symptomatic periods has been raised 
to an average of once a week from the previous three times per 
month.  It is no longer assumed that pain necessarily begins at the 
same time changes in stools frequency and consistency occur, but 
rather that of symptoms association. Pain relief after defecation 
has been removed from the criteria and replaced by pain related 
to defecation. Finally, subtyping of IBS into diarrhea-predominant, 
constipation-predominant, mixed or unsubtyped is now not 
dependent on specific numerical percentages of specific stool 
types but on the patient’s report of the stool frequency of types 
based on the standard Bristol Stool Scale.4  




• Constipation & / or alternating with 
• Diarrhoea
Upper GI




When investigating the pathophysiology of IBS, the literature 
includes several possible factors, including disturbed motility, the 
gut-brain axis (GBA), genetic factors, impaired gut-barrier function, 
immunologic dysregulation, the gut microbiome and psychological 
factors.1
The contractions and relaxation of the GIT (gastrointestinal tract) 
necessary to move food through the GIT is called gastrointestinal 
motility. Many factors, for example physical exercise and emotional 
distress can affect motility. More recently, there is evidence that low-
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Table 1: Differences between the Rome III and Rome IV criteria for diagnosing IBS
The Rome III Criteria states that IBS includes:4
The Rome IV Criteria states that IBS is characterized by 
(more recently published):4
Recurrent abdominal pain or discomfort at least 3 days per month for past 3 
months, with symptom onset >6 months before diagnosis, associated with 2 
or more of the following:
• Improvement with defecation
• Onset associated with a change in frequency of stool
• Onset associated with a change in stool form /appearance
Recurrent abdominal pain on average at least 1 day a week in the last 3 
months associated with two or more of the following:
• Associated with a change in a frequency of stool
• Associated with a change in form (consistency) of stool.
• Symptoms must have started at least in the preceding 6 months 
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grade mucosal inflammation and immune activation (particularly 
with mast cell involvement) in association with impaired epithelial 
barrier function and neuronal sensitivity may play a role in functional 
gastrointestinal disorders.1
The GBA denotes a phenomenon of two-way communication between 
the central and the enteric nervous system, linking emotional and 
cognitive centers of the brain with peripheral intestinal functions. The 
interaction between microbiota and GBA occurs through signaling 
from gut-microbiota to brain and from brain to gut-microbiota by 
means of neural, endocrine, immune, and humoral links.5 The 
available evidence indicates that both brain-gut and gut-brain 
dysfunctions may occur, the former being dominant particularly in 
irritable bowel syndrome (IBS). The disruption occurring in the GBA 
determines the changes in intestinal motility and secretion, causes 
visceral hypersensitivity and leads to cellular alterations of the 
entero-endocrine and immune systems. Microbiota may interplay 
with multiple of these different pathophysiological IBS targets.5
Case study 
Mrs. K, a 38-year-old female made an appointment out of her 
own accord with the dietitian regarding her ongoing 8 years battle 
with irritable bowel syndrome (IBS). She had previously seen a 
gastroenterologist who confirmed her diagnosis.
Medical conditions relevant to IBS included post-traumatic stress 
disorder (PTSD) post birth of a child. Previous herbal/natural anti-
depressants were used and the patient has a history of using a PPI 
(Proton pump inhibitor) and Sucralfate (liquid antacid) as needed 
due to stomach ulcers (approximately 9 years ago). Her current 
medication included Mebeverine (135 mg tablets; a well-known 
anti-spasmodic) and “anti-nausea” (Cyclizine 50mg tablets) as 
needed. A probiotic (9-strain) capsule was taken once per day. Her 
symptoms included bloating and gassiness, loose bowel movements 
up to four times per day as well as episodes of cold sweats, shaking 
and severe diarrhoea when eating out at family or restaurants; 
especially if food eaten was fatty /oily and alcohol was consumed.
Gastroscopy and colonoscopy were normal, as was her lactose 
tolerance test, all performed in 2015.  
Lactose tolerance can be tested using the hydrogen breath test 
or blood tests.6 Testing is ordered when a person has signs and 
symptoms that suggest lactose intolerance that develop 30 minutes 
to 2 hours after ingesting milk or other dairy products. Some of 
these include abdominal pain and bloating, diarrhoea, nausea and or 
flatulence. With hydrogen breath testing, a baseline breath sample 
is taken before giving a lactose-loaded drink. If the hydrogen gas in 
a person’s breath significantly increases from the baseline, then it is 
likely that the person is lactose intolerant.6
In this case, timed samples of blood were taken and measured for 
glucose following a standard dose (100 g) of lactose orally. If the 
glucose levels following the lactose ingestion do not increase, yet 
the person still has symptoms consistent with lactose intolerance, 
then the condition is likely present. Increasing blood glucose levels 
over the course of the test indicate that signs and symptoms are 
unlikely to be due to lactose intolerance. In this patient’s case, blood 
glucose rose to 1.8 mmol/l (a blood glucose rise above 1.7 mmol/l 
at any point in the test considered normal).6 However, the patient 
volunteered that she definitely “reacted” to dairy products and that 
there was a family history of lactose intolerance.
Further upon evaluation, the patient enjoyed running and her dietary 
history was remarkable for an alcohol intake of 1–2 glasses white 
wine per night, max 3–4 glasses over the weekend; occasional Irish 
coffee; chewing gum during the day; a fluid intake of coffee 2–3 
cups per day, Ceylon tea, flavoured water and water, a high fibre diet 
(consisting of  bran or muesli rusks, seed loaf bread, fruits such as 
apple, plenty of vegetables); cheese, nuts and biltong; and evening 
meals were sometimes ready to eat, purchased from a food shop.
 Treatment
The patient was asked to keep a food and symptoms diary for 3 
weeks, was provided with the general IBS dietary guidelines as well 
as a meal plan with sufficient energy, and was advised to use lactose 
free milk. 
Follow up three weeks after the initial consultation:
The patient reported a definite improvement in symptoms when 
cutting down on her caffeine intake and replacing it with more water 
and rooibos tea. The patient also recorded one episode of shaking 
and diarrhoea when eating out at a restaurant.
Lactose free milk appeared to elicit fewer problems with her colon. 
Dairy definitely caused cramps and pain, especially when cheese 
was consumed in large portions. Trigger foods identified through 
a comprehensive food diary included: onion, especially raw, garlic, 
fatty foods, especially cheese cake and take-away burger and chips.
The patient was relieved to see that with the changes in her diet, 
her bowel movements were more formed and a normal pattern was 
established. Mebeverine was used occasionally before a meal, if the 
patient felt particularly uncomfortable.
Dietary modifications for IBS symptoms
Dietary and lifestyle modification can be beneficial for these patients, 
as more than 60% of IBS patients report worsening symptoms after 
meals, sometimes directly after meals, but more often within 3 hours 
of eating.1 Individual dietary counselling and including more soluble 
fibre, and avoiding insoluble fibre and high-FODMAP (fermentable 
oligo di and monosaccharides and polyols) foods (Table 2) can be 
highly beneficial to this patient population.2
The dietary treatment of IBS has been a much debated and 
researched topic in recent years. Unfortunately, patients often go 
to extreme measures and are subjected to a plethora of dietary 
information from different sources before consulting a medical 
professional. 
Trigger foods most sighted by patients include milk and dairy 
products, wheat products, caffeine, cabbage, onions, peas, hot 
spices and fried and smoked foods.2 Patients often sight food 
allergies or intolerances as the basis of their IBS symptoms. In truth, 
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true food allergies are present in 1–4% of the population, but are not 
more prevalent in IBS.2
There is evidence of some changes in nutrient-related GI functions 
in IBS, for example exaggerating gastro-colonic reflex, enhanced 
sensitization to rectal distention after consuming fat, and changes 
in colonic bacterial flora that may be relevant for the fermentation of 
non-absorbable foods.1
The British Dietetic Association provides a dietetic care pathway 
followed by a systemic treatment, including 3 lines of dietary 
management for IBS3:
• First-line: clinical and dietary evaluation and healthy eating 
management with general guidance on lactose and non-starch 
polysaccharides (NSP).
• Second-line: dietary interventions to alleviate symptoms 
resulting from NSP and fermentable carbohydrates and use of 
probiotics.
• Third-line: elimination and empirical diets.
Dietary guidelines should be provided to patient based on symptoms 
and adjusted to the sub-type of IBS the patient is suffering from.3 
FODMAPs
FODMAPS are Fermentable Oligo (fructans {inulin,FOS} – CHO 
chain >10 & galactans) Disaccharides (lactose) Monosaccharides 
(fructose)  And Polyols  (sorbitol, mannitol, xylitol, maltitol).7
Short chain carbohydrates are poorly absorbed in the small intestine, 
enter the colon, and are fermented, causing gas and distention.6 
Manipulation of diet may affect gas production and symptoms in IBS 
patients. Studies have shown that up to three quarters of patients 
with IBS responded favourably (symptoms were reduced) when 
FODMAPs (Table 2) were restricted.  Patients should be advised to 
follow a low-FODMAP diet for 6-8 weeks, and then start to broaden 
the scope of the diet, examining their tolerance to different foods in 
order to stabilise their diet in the longer term.8
Fructose intake has increased over the decades due to increase fruit 
juices and high fructose corn syrup in foods and beverages. Fructose 
relies on glucose transporters for absorption and an ingestion of large 
amounts of fructose can cause malabsorption. Fructose distends the 
small bowel with water, causing bloating.8 
If food/beverage contains small amounts fructose and glucose, then 
they are allowed on low FODMAP diet, as glucose enhances fructose 
absorption.7
Although this approach is successful in many patients, the low-
FODMAP diet is very restrictive and requires intense dietetic input. 
Only a minority of the initially restricted foods are avoided in the 
longer term diet, most likely because of the individual variance in the 
severity of malabsorption and bacterial fermentation of malabsorbed 
carboydrates.7
The role of probiotics in IBS
A probiotic is a live microbial organism that, when ingested in 
beneficial numbers, can provide a health benefit to the host. 
Most common microbial organisms include Lactobacilli and 
Bifidobacteria.8-10 Studies have shown improvement in IBS visceral 
hypersensitivity, dysmotility, intestinal permeability and improved 
immune function with the use of probiotics. Bifidobacterium infantis 
35624 at a dose of 1 X 108 CFUs per day, taken for at least a month 
resulted in reduced pain, bloating and improved bowel satisfaction 
scores in IBS.11  
Gut microbiota is thought to play important roles in the pathogenesis 
of IBS. This is evident from the fact that IBS occurs more frequently 
after intestinal infection or antibiotics treatment. Studies have shown 
a change in the intestinal microbiota observed in IBS patients.11 
Published studies have reported an incidence of post infective IBS 
to range between 5% and 32%.11 The mechanisms underlying the 
development of this are not fully understood, but are believed to 
include persistent sub-clinical inflammation, changes in intestinal 
permeability and alteration of gut microflora. Considering the 
relationship between alteration of gut microflora and inflammation 
of the gut, manipulation of the gut microbiota by probiotics appears 
Table 2:  Foods high in FODMAPs7, 9







• High-fructose corn syrup






• Milk (cow, goat, sheep)
• Yoghurt
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to be beneficial treatment for IBS. However, the beneficial effects 
and efficacy of altering gut microbiota by probiotics to improve 
the symptoms of IBS have not been consistent in clinical trials and 
further research is needed.12
It is important to keep in mind that in order for probiotics to be 
effective, they must be acid enzyme resistant, have good mucosal 
adherence and be consumed in sufficient quantities. Regular intake 
for at least 4 weeks is advised, and then continued use if the desired 
effect was observed.  It is also important to warn patients that 
probiotics are generally regarded as safe in the treatment of IBS, but 
some may experience aggravated symptoms.13
Conclusion
IBS is a complex disorder, affecting patients’ quality of life. As its 
pathophysiology includes psychological, physiological and dietary 
factors, a holistic approach is needed in the management of 
symptoms. As every individual’s circumstances are different, it is 
important to take into account the patients’ dietary habits as well 
as their daily routine. An individualized approach, avoiding trigger 
foods and circumstances, as well as providing ongoing nutrition 
counselling can significantly improve symptoms as well as a feeling 
of autonomy in these patients.
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Table 3: Probiotic preparations shown to have an effect on IBS symptoms in adults11





Mixture (L ramnossus, L salivarius, S faecium, L reuterii)
Pain reduction Bifidobacterium infantis 35624
Mixture (4 strain)
Less bloating and flatulence VSL#3
